Average Co-Inventor Count = 10.08
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (9 from 3,222 patents)
2. Xrad Therapeutics, Inc. (1 from 1 patent)
3. F. Hoffmann-la Roche Ag (168 patents)
10 patents:
1. 12187742 - Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy
2. 11760744 - Fused ring compounds
3. 11034692 - Naphthyridines as inhibitors of HPK1
4. 10913742 - Oxadiazolones as transient receptor potential channel inhibitors
5. 10711004 - Oxadiazole transient receptor potential channel inhibitors
6. 10435414 - Tricyclic PI3K inhibitor compounds and methods of use
7. 10407424 - Naphthyridines as inhibitors of HPK1
8. 10280165 - Pyridopyrimidinones and methods of use thereof
9. 10179782 - Substituted sulfonamide compounds
10. 10065970 - Tricyclic PI3K inhibitor compounds and methods of use